Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
Saved in:
Main Authors: | Minglu Liu (Author), Tong Hu (Author), Wenfeng Gou (Author), Huajie Chang (Author), Yanli Li (Author), Yiliang Li (Author), Daiying Zuo (Author), Wenbin Hou (Author), Shunchang Jiao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
by: Minglu Liu, et al.
Published: (2022) -
Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology
by: Zhong Xue, et al.
Published: (2023) -
A comparative study on the in vitro and in vivo antitumor efficacy of icaritin and hydrous icaritin nanorods
by: Haowen Li, et al.
Published: (2020) -
Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations
by: Junjun Ling, et al.
Published: (2022) -
Author correction to 'Discovery of the radio-protecting effect of ecliptae herba, its constituents and targeting p53-mediated apoptosis in vitro and in vivo' [Acta Pharm Sin B 13 (2023) 1216-1230]
by: Jiang Wu, et al.
Published: (2023)